We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Novel Microneedle Patch Immediately Stops Bleeding After Injury

By HospiMedica International staff writers
Posted on 24 Jan 2023
Print article
Image: Hemostatic microneedle technology can be applied like a typical adhesive bandage to quickly stop bleeding (Photo courtesy of Penn State)
Image: Hemostatic microneedle technology can be applied like a typical adhesive bandage to quickly stop bleeding (Photo courtesy of Penn State)

Secondary, uncontrolled bleeding from traumatic injury is a leading cause of death. That could now change with a novel microneedle patch that is capable of immediately stopping bleeding after injury.

The hemostatic microneedle technology developed by researchers at Penn State (University Park, PA, USA) can be applied like a typical adhesive bandage to quickly stop bleeding. The biocompatible and biodegradable microneedle arrays (MNAs) on the patch increase its surface contact with blood and accelerate the clotting process. The needles also increase the adhesive properties of the patch through mechanical interlocking to promote wound closure.

The MNA patch is similar to the hydrogel technology currently used to treat bleeding wounds in hospitals, although hydrogel applications need preparation and medical expertise. In contrast, the microneedle patch is pre-engineered for immediate application so that it can be used by anyone to stop bleeding, similar to an adhesive bandage that is available over-the-counter. Microneedles are already being used to deliver biologics, such as cells or drugs, through the skin or for cosmetic procedures to stimulate collagen production. They are tiny, making their application pain-free. The researchers now plan to bring the patch from the lab to the market by further testing the technology.

“Excessive bleeding is a serious challenge for human health. With hemorrhaging injuries, it is often the loss of blood - not the injury itself - that causes death. There is an unmet medical need for ready-to-use biomaterials that promote rapid blood coagulation,” said Amir Sheikhi, assistant professor of chemical engineering and of biomedical engineering at Penn State. “In vitro, the engineered MNAs reduced clotting time from 11.5 minutes to 1.3 minutes; and in a rat liver bleeding model, they reduced bleeding by more than 90%. Those 10 minutes could be the difference between life and death.”

Related Links:
Penn State 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Washer Disinfector
TIVA 10-M

Print article

Channels

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.